Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
86 |
Employees |
- |
Revenues (TTM) (Millions $) |
227 |
Net Income (TTM) (Millions $) |
-24 |
Cash Flow (TTM) (Millions $) |
-7 |
Capital Exp. (TTM) (Millions $) |
3 |
Cadence Pharmaceuticals Inc
Cadence Pharmaceuticals Inc. was a biopharmaceutical company based in San Diego, California. It focused on the development and commercialization of therapies to treat acute and chronic pain and other related conditions. The company's flagship product was OFIRMEV', an intravenous medication used to manage pain and fever. Cadence Pharmaceuticals Inc. was acquired by Mallinckrodt Pharmaceuticals in 2014.
|